http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
김석관(Seok-Kwan Kim),류갑상(Gab-Sang Ryu) 한국정보전자통신기술학회 2018 한국정보전자통신기술학회논문지 Vol.11 No.3
중견/중소 IT기업의 사업 수행 기회 증대, 기회 균등과 역량 강화라는 취지로 소프트웨어(SW)산업진흥법 개정으로 공공정보화시장에 대기업 참여를 제한되었다. 이러한 환경에서의 중견/중소 SW기업들의 사업을 수행하면서 발생한 사업 수행 역량 미흡으로 공공정보화사업의 품질저하, 위험관리 미숙, 일정관리 저하 등 여러 문제점을 발생시키고 있다. 이를 해결하기 위해 본 논문은 시스템통합 사업 수행 시 품질 저하 요인을 도출하였으며, 이를 해결하기 위한 방안으로 VISUALIZATION, 엄격한 시험관리, Agile방법론의 일부 활동을 적용하여 프로젝트를 수행하는 것을 제안했다. 이러한 방안을 중견/중소 IT기업이 개발한 보건의료 IT 프로젝트에 적용한 결과 의사소통의 개선, 수치화된 진척 관리 및 프로젝트의 가시성이 개선되었다. 또한, 결함 해결시간 최소화, 요구사항 커리리지 비율 개선, 불필요한 회의시간이 단축이 되어 품질 향상에 기여하였습니다. This paper limited the participation of large corporations in the mass information market by revising the Software Industry Promotion Act in order to increase business opportunity, equality of opportunity, and capacity building for small and medium sized IT companies. However, it is a fact that the medium and small SW companies have insufficient business capacity and expose various problems such as quality degradation of public information business, inadequate risk management, and deterioration of schedule management. In order to solve this problem, this paper derived the factors of quality deterioration in the system integration project and proposed to carry out the project by using some activities of VISUALIZATION, rigorous test management and Agile Methodology as a solution. Applying these measures to healthcare IT projects developed by midsize / small-sized IT companies has improved communications, improved quantitative progress management and improved project visibility. In addition, it contributed to minimizing defect resolution time, improving the requirement coverage ratio, and shortening unnecessary meeting time.
바이오경제시대 과학기술정책의제 연구사업(8차년도) - 제2권: 면역항암제 개발 동향과 시사점 -
김석관(Seok-Kwan Kim),박수영(Sooyoung Park),신예린(Yerin Shin),조용범(Yongbeom Cho),신춘봉(Chun-Feng Xin),도준상 과학기술정책연구원 2019 정책연구 Vol.- No.-
In the field of cancer treatment, the progress of immunotherapy has been impressive over the past decade, and the paradigm of cancer treatment is at a turning point. Cancer immunotherapy, called third-generation anticancer drugs, are drugs that cause immune cells to directly kill cancer cells by regulating or enhancing immune cell functions in the body. It overcomes the limitations of the first generation chemotherapy and second generation target therapy. The incredible success of curing the intractable cancer patients is raising hopes that humankind may conquer cancer and opens up new market opportunities for pharmaceutical companies and start-ups. However, research and development in the field of immunotherapy were not actively pursued in Korea and policy responses are lacking. The major reason for this is that the scale of cancer immunotherapy is small, but the technical barriers to understanding cancer immunotherapy are high, suggesting the lack of a policy debate. Therefore, in order to move policy and strategic discussions about cancer immunotherapy forward more actively, a research report about current trends is necessary. This should include easy-to-understand technical explanations enabling non-experts to understand them easily. The purpose of this research is to explain the basics of cancer immunotherapy and to provide the latest information on emerging trends in cancer immunotherapy. Cancer immunotherapy can be divided into several subdivisions, and each category is complex when it comes to the technical details. Therefore, in this research, we focus on two areas that are receiving the greatest attention in recent years, "immune checkpoint Inhibitor’ and ‘CAR-T immunotherapy’ The content of this research is structured as follows. Chapter 1 explains the background, necessity and purpose of the study. The historical development of cancer therapy and the subsequent rise of cancer immunotherapy are briefly mentioned. Chapter 2 explains the possibility of immuno-chemotherapy through providing a basic understanding of the immune system in the context of anti-cancer immunity. In addition, the scope of the cancer immunotherapy analyzed in this study is outlined. Chapters 3 and 4 contain a review of basic mechanisms, outcomes, limitations, and global trends of the immune checkpoint inhibitors and the CAR-T immunotherapy, respectively. "Immune checkpoint inhibitors" are the first immunotherapeutic drugs that demonstrate efficacy and are FDA approved. CAR-T, the most promising therapy among various genetic manipulation immunotherapy strategies is mainly described. Chapter 5 suggests policy implications of the emerging cancer immunotherapy trends. In this chapter, we propose ‘biotechnology innovation policy in a broad context’ and ‘strategy for the development of cancer immunotherapy in a narrow context’.
신기술 발전에 따른 산업 지형의 변화 전망과 대응 전략
김석관(Seok-Kwan Kim),이성호(Sung-ho Lee),최병삼(Byong-Sam Choi),이상엽(Sang-Yup Lee),장병열(Pyoung-Yol Jang) 과학기술정책연구원 2015 정책연구 Vol.- No.-
Technological changes have been major factors triggering drastic changes of industrial landscapes. Emerging technologies have double-sided potentials to incumbent firms: they can be winner and also be looser. We developed a common framework to foresight the impacts on industrial structure of emerging technologies and applied it to 4 emerging technology areas: cognitive computing, 3D printing, internet of things, fintech. In each cases, we studied technological trends, changes of products, processes, services and business models, and structural changes of industrial landscapes. And we also examined main drivers and constraints moderating these changes. On the basis of these analysis, we suggest some policy recommendations and theoretical implications.
한국형 발전모델의 탐색과 성장동력 정책의 전환 - 제3권 한국 경제의 성장경로 분석 및 국가 발전모델 비교 -
김석관(Seok-Kwan Kim),추수진(Soo Jin Choo),이예원(Ye Won Lee) 과학기술정책연구원 2019 정책연구 Vol.- No.-
This research aims to analyze Korea"s growth path from the perspective of co-evolution of technology-organization-institution, identify organizational and institutional legacies formed in Korea in the course of compressed growth, and suggest what institutional transformation is necessary to pursue a new growth path in response to the digital transformation of the fourth industrial revolution. South Korea is moving from coordinated market economy (CME) to liberal market economy (LME) in the course of the 1997 financial crisis and subsequent structural reforms, and as a result, there is a mix of CME and LME systems. Korea has succeeded in pursuing a certain portion of both Science, Technology and Innovation (STI) and Learning by Doing, Using and Interacting (DUI) industries, but the pursuit is difficult in the extreme areas where STI or DUI attributes are strongly displayed, and this is because Korea"s institutional system is neither CME nor LME. From an institutional perspective, the digital transformation of the fourth industrial revolution calls for an institutional transition to LME, while the demand for localization of materials, parts and equipment triggered by recent export regulations by Japan calls for a return to CME. For Korea, an institutional mixed country with CME and LME, both directions are hard to give up, and this is the dilemma facing the Korean economy. Given the complementarity of the institution and the experience of history, it seems difficult to pursue both CME and LME at the same time, but the possibility of a mixed system of "LME-based, CME-complemented" types is also visible due to the spread of the LME system due to globalization and the decrease of the importance of proficiency due to digitalization. The institutional transition tasks, which should be pursued first for Korea’s innovation growth, include a virtuous circle of venture capital investment, a negative regulatory system, a manufacturing proficiency accumulation system, and the elimination of unbalanced relations between large and small- and medium-sized businesses.
김석관(Seok-Kwan Kim),최병삼(Byong-Sam Choi),양희태(Hee Tae Yang),장필성(Pilseong Jang),손수정(Soo J. Sohn),장병열(Pyoung Yol Jang),이제영(Jei Young Lee),김승현(SeungHyun Kim),이다은(Daeun Lee),김단비(Danbi Kim),송성수(Sungsoo Song) 과학기술정책연구원 2017 정책연구 Vol.- No.-
Since the ’Fourth Industrial Revolution’ was first introduced in January 2016, this new term has been rapidly adopted by the Korean policy scene and the public. But the doubts and conceptual controversies about its reality persisted for last two years. The purpose of this study is to examine the feasibility of the 4th Industrial Revolution and to lay the foundations for the related policy discussions to be made on a more sound theoretical and conceptual basis through the following works. First, we found the conditions for the establishment of industrial revolution from the history of industrial revolutions. Second, we redefined the technological drivers of the Fourth Industrial Revolution from recent phenomena. Third, we made an outlook at what kind of industrial change this technological driver will bring and judged whether it would be a new industrial revolution. Fourth, policy implications for the response of the Fourth Industrial Revolution are derived from the understanding of the process of industrial change. Through this work, we have come to the conclusion that we are open to the possibility that a new industrial revolution will come, but this has to be confirmed through increased productivity, and in that case it is more appropriate to call it third industrial revolution rather than fourth one. Based on the observation that there are two types of fourth industrial revolution, we conclude that the most important challenge that the fourth industrial revolution bring to Korea will be institutional innovation. In addition, 5 innovation policy agenda for accelerating digital transformation are proposed: mitigation of entry regulation, expanding data infrastructure, enhancing entrepreneurial ecosystem, launching the }R&D New Deal’, and developing SW talents.